November 2, 2023
PharmaZac sponsors the medical book “The Neuropsychology of Epilepsy” of Dr. P. Patrikelis Neuropsychologist Ph.D University of Ioannina Medical School and Dr. S. Gatzonis, Neurologist Dep. […]
November 2, 2023
Pharmazac S.A participates in the online CPhI festival of pharma 2020
November 2, 2023
Pharmazac has released the new product Calcium Folinate, an injectable solution 200mg/20ml Bt x 1 vial x20ml for intravenous or intramuscular use. Calcium Folinate / Pharmazac is the only available generic product in the Greek market.
November 2, 2023
Pharmazac has released the new product Ractilen (rasagiline tabs 1mg/tab ) for the treatment of PD
November 2, 2023
Pharmazac has released the new product Nitastin 20mg film coated tablet for treatment of heart disease In addition to the hypolipidemic actions Nitastin has beneficial effects […]
November 2, 2023
Pharmazac launched the first Rosuvastatin generic in the Greek Pharmaceutical Market. Rosuvastatin is available in two forms of 14 and 30 film coated tablets and composition of […]
November 2, 2023
November 2, 2023
Pharmazac a Member of the Hellenic Association of Pharmaceutical Companies, announces the completion of the successful Conference of the Hellenic Society of Headache, that took place […]
November 2, 2023
Pharmazac launched the new product Quental/quetiapine 50,200,300 and 400mg in prolonged release tablets for the treatment of schizophrenia and bipolar disorders.
